I hope to see holders tune in and ask the important questions.I personally will ask the below if given the opportunity:1) Why is revenue uptick been sluggish for a proven product, with the company having soo many regulatory approvals and market education going on; What is the real barrier here ? Is it cost ? or something more pressing ?2) Is there an update on CR ? The company is playing it too close to the chest with liquidity - this is clearly hurting SP - is there a plan for an institutional placement ?3) Understand the focus on China - however, India is another high populous nation - why are we not seeing revenue uptick over there ? It's not even 10 - 20K in revenue out of India - why is that ?
I hope to see holders tune in and ask the important questions.I...
Add OSX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
-0.005(6.49%) |
Mkt cap ! $7.845M | |||
| Open | High | Low | Value | Volume |
| 8.2¢ | 9.8¢ | 6.8¢ | $1.559M | 19.01M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 36546 | 7.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.3¢ | 83000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.1¢ |
Change
-0.005 ( 6.46 %) |
||||
| Open | High | Low | Volume | ||
| 8.1¢ | 9.8¢ | 6.8¢ | 5273787 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| OSX (ASX) Chart |